Fatigue and issues with cognition represented the most common and disabling symptoms associated with myeloproliferative neoplasms, according to findings published in Psycho Oncology . The study team conducted an online survey to...
Read More
The following is a summary of “Predictive significance of high neutrophil ratio for thrombosis in...
Read More
THURSDAY, May 23, 2024 (HealthDay News) — Metformin use, including long-term use, is...
Read MoreHigher neutrophil-to-lymphocyte ratio (NLR) and comorbidity burden in myeloproliferative neoplasms (MPN) are associated with decreased survival.
Read MoreThe Janus kinase 2 (JAK2)-driven myeloproliferative neoplasms (MPNs) are chronic malignancies associated with high-risk complications and suboptimal responses to JAK inhibitors such as ruxolitinib. A better understanding of...
Read MoreThe Janus kinase 2 (JAK2)-driven myeloproliferative neoplasms (MPNs) are chronic malignancies associated with high-risk complications and suboptimal responses to JAK inhibitors such as ruxolitinib. A better understanding of...
Read More
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are a group of rare and heterogeneous...
Read More
Classic BCR/ABL1-negative myeloproliferative neoplasms (MPNs) are characterized by clinical and...
Read More
Myeloproliferative neoplasms (MPNs) are characterized by significant symptom burden. Integrative...
Read More
Myeloproliferative neoplasms (MPNs) are a group of diseases that cause myeloid hematopoietic cells...
Read More
Defective cholesterol efflux pathways in mice promote the expansion of hematopoietic stem and...
Read More
Treatment options are limited for patients with advanced forms of myeloproliferative neoplasms...
Read More
Myeloproliferative neoplasms (MPNs) include polycythemia vera (PV), essential thrombocythemia...
Read More
Patients with myeloproliferative neoplasms (MPNs), such as polycythemia vera, essential...
Read More
To explore the risk factors of thrombosis in patients with JAK2 -mutated myeloproliferative...
Read More
FRIDAY, Aug. 11, 2023 (HealthDay News) — For patients with suspected myelodysplastic...
Read More
The most prevalent mutations predisposing to acute myeloid leukemia (AML)/myelodysplastic syndrome...
Read More
Myeloproliferative neoplasms (MPNs) are a diverse group of chronic hematological diseases caused...
Read More
To summarize cases submitted to the 2019 Society for Hematopathology/European Association for...
Read More
This review reflects the presentations and discussion at the 14th post-ASH International Workshop...
Read More
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
